E-LIB Suche - Ergebnisse für: Landovitz, Raphael J

1

Long-acting cabotegravir pharmacokinetics with and without ..:

Han, Kelong ; Patel, Parul ; McCallister, Scott...
Antimicrobial Agents and Chemotherapy. , 2024

2

HPTN 083‐02: factors influencing adherence to injectable Pr..:

Psaros, Christina ; Goodman, Georgia R. ; Lee, Jasper S....
Journal of the International AIDS Society. 27 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

3

The impact of intimate partner violence on PrEP adherence a..:

Anderson, Katherine M. ; Blumenthal, Jill ; Jain, Sonia...
BMC Public Health. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

4

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adhe..:

Landovitz, Raphael J ; Tao, Li ; Yang, Juan...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

5

A linked physiologically based pharmacokinetic model for hy..:

Steinbronn, Claire ; Chhonker, Yashpal S. ; Stewart, Jenell...
Clinical and Translational Science. 16 (2023) 7 - p. 1243-1257 , 2023

Link: https://doi.org/10.1111/..

6

Prevention, treatment and cure of HIV infection:

Landovitz, Raphael J. ; Scott, Hyman ; Deeks, Steven G.
Nature Reviews Microbiology. , 2023

Link: https://doi.org/10.1038/..

7

Estimating the impact of HIV PrEP regimens containing long-..:

Mitchell, Kate M. ; Boily, Marie-Claude ; Hanscom, Brett...
The Lancet Regional Health - Americas. 18 (2023) - p. 100416 , 2023

Link: https://doi.org/10.1016/..

8

Efficacy and safety of long-acting cabotegravir compared wi..:

Landovitz, Raphael J ; Hanscom, Brett S ; Clement, Meredith E...
The Lancet HIV. 10 (2023) 12 - p. e767-e778 , 2023

Link: https://doi.org/10.1016/..

9

Predicted effects of the introduction of long-acting inject..:

Smith, Jennifer ; Bansi-Matharu, Loveleen ; Cambiano, Valentina...
The Lancet HIV. 10 (2023) 4 - p. e254-e265 , 2023

Link: https://doi.org/10.1016/..

10

Novel Approaches to Postnatal Prophylaxis to Eliminate Vert..:

Ruel, Theodore ; Penazzato, Martina ; Zech, Jennifer M....
Global Health: Science and Practice. 11 (2023) 2 - p. e2200401 , 2023

Link: https://doi.org/10.9745/..

11

Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who..:

Amick, Alyssa K ; Eskibozkurt, G Ege ; Hosek, Sybil G...
Clinical Infectious Diseases. 78 (2023) 2 - p. 402-410 , 2023

Link: https://doi.org/10.1093/..

12

Development and validation of a liquid chromatographic-tand..:

Weld, Ethel D. ; Parsons, Teresa L. ; Gollings, Ryann...
Journal of Pharmaceutical and Biomedical Analysis. 228 (2023) - p. 115307 , 2023

Link: https://doi.org/10.1016/..

13

Efficacy, safety, tolerability, and pharmacokinetics of lon..:

Marzinke, Mark A ; Hanscom, Brett ; Wang, Zhe...
The Lancet HIV. 10 (2023) 11 - p. e703-e712 , 2023

Link: https://doi.org/10.1016/..

14

Extended Analysis of HIV Infection in Cisgender Men and Tra..:

Marzinke, Mark A. ; Fogel, Jessica M. ; Wang, Zhe...
Antimicrobial Agents and Chemotherapy. 67 (2023) 4 - p. , 2023

Link: https://doi.org/10.1128/..

15

Evaluating group-sequential non-inferiority clinical trials..:

Hanscom, Brett S ; Donnell, Deborah J ; Fleming, Thomas R...
Clinical Trials. 19 (2022) 6 - p. 605-612 , 2022

Link: https://doi.org/10.1177/..